Literature DB >> 15737684

Selective induction of apoptosis in murine skin carcinoma cells (CH72) by an ethanol extract of Lentinula edodes.

Yu-Huan Gu1, Martha A Belury.   

Abstract

The effects of ethanol extracts from four species of mushroom fruiting bodies, mushroom spores and mushroom cultured broth, were assessed for modulation of cell proliferation and apoptosis in murine skin carcinoma cells (CH72) and non-tumorigenic epidermal cells (C50). While extracts from mycelia of Grifola frondosa, Ganoderma lucidum, Hericium erinaceus, or from spores of G. lucidum exerted little, if any, effect on proliferation, the ethanol-soluble extract of Lentinula edodes (L. edodes) significantly decreased cell proliferation of CH72 cells. There were no changes in the proliferative response of the non-tumorigenic keratinocyte cell line, C50, to any of the mushroom extracts tested. To analyze cell proliferation and apoptosis, fluorescent DNA-microscopy with ethidium bromide and acridine orange staining of cells revealed L. edodes reduced cell proliferation and induced apoptosis in time- and dose-dependent manners in carcinoma cells but had no effect in non-tumorigenic cells (C50). Cell cycle analysis demonstrated that L. edodes extract induced a transient G(1) arrest, with no changes observed in the non-tumorigenic cells (C50).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15737684     DOI: 10.1016/j.canlet.2004.06.037

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

Review 1.  Medicinal mushroom: boon for therapeutic applications.

Authors:  Vivek Kumar Chaturvedi; Sonam Agarwal; Krishna Kumar Gupta; Pramod W Ramteke; M P Singh
Journal:  3 Biotech       Date:  2018-07-23       Impact factor: 2.406

2.  Optimization of UV irradiation conditions for the vitamin D2-fortified shiitake mushroom (Lentinula edodes) using response surface methodology.

Authors:  Jung A Ko; Hyun Jin Park; Dong Jae Won; Sun Young Kim; Cheol Ho Jang; Jin Sil Lee
Journal:  Food Sci Biotechnol       Date:  2017-12-12       Impact factor: 2.391

3.  Ganoderma lucidum polysaccharides in human monocytic leukemia cells: from gene expression to network construction.

Authors:  Kun-Chieh Cheng; Hsuan-Cheng Huang; Jenn-Han Chen; Jia-Wei Hsu; Hsu-Chieh Cheng; Chern-Han Ou; Wen-Bin Yang; Shui-Tein Chen; Chi-Huey Wong; Hsueh-Fen Juan
Journal:  BMC Genomics       Date:  2007-11-09       Impact factor: 3.969

4.  A polysaccharide from Lentinus edodes inhibits human colon cancer cell proliferation and suppresses tumor growth in athymic nude mice.

Authors:  Jinglin Wang; Weiyong Li; Xiao Huang; Ying Liu; Qiang Li; Ziming Zheng; Kaiping Wang
Journal:  Oncotarget       Date:  2017-01-03

5.  Ethyl Acetate Fraction of Aqueous Extract of Lentinula edodes Inhibits Osteoclastogenesis by Suppressing NFATc1 Expression.

Authors:  Hyerim Lee; Kyubin Lee; Sheunghun Lee; Jisu Lee; Won Tae Jeong; Heung Bin Lim; Tae Kyung Hyun; Sun-Ju Yi; Kyunghwan Kim
Journal:  Int J Mol Sci       Date:  2020-02-17       Impact factor: 5.923

6.  Anticancer Activity of Solvent Extracts of Hexogonia glabra against Cervical Cancer Cell Lines.

Authors:  Swapan Kumar Ghosh; Tapojyoti Sanyal; Tanmay Bera
Journal:  Asian Pac J Cancer Prev       Date:  2020-07-01

7.  Synergistic Cytotoxic Effects of Ganoderma lucidum and Bacillus Calmette Guérin on Premalignant Urothelial HUC-PC Cells and Its Regulation on Proinflammatory Cytokine Secretion.

Authors:  John Wai-Man Yuen; Mayur-Danny I Gohel; Chi-Fai Ng
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-28       Impact factor: 2.629

8.  Recent developments in mushrooms as anti-cancer therapeutics: a review.

Authors:  Seema Patel; Arun Goyal
Journal:  3 Biotech       Date:  2011-11-25       Impact factor: 2.406

9.  Lentinan inhibits tumor angiogenesis via interferon γ and in a T cell independent manner.

Authors:  Shengming Deng; Guoxi Zhang; Jiajie Kuai; Peng Fan; Xuexiang Wang; Pei Zhou; Dan Yang; Xichen Zheng; Xiaomei Liu; Qunli Wu; Yuhui Huang
Journal:  J Exp Clin Cancer Res       Date:  2018-10-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.